Cutaneous and biophysical changes among patients receiving treatment with epidermal growth factor receptor inhibitors (EGFRI)

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2023)

引用 0|浏览1
暂无评分
摘要
Background: EGFRI are a targeted therapy for advanced-stage solid organ cancers. Cutaneous toxicities are well known adverse events. However, prospective long-term data on cutaneous biophysical changes after the drug use is limited.
更多
查看译文
关键词
epidermal growth factor,egfri,growth factor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要